Abrams Capital Management
13F Holdings and Portfolio Analysis
David Abrams 2019 Q4 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Abrams Capital Management Overview
Abrams Capital Management held 21 stocks in 2019 Q4, with total market value around $3.22B.
Abrams Capital Management's top five holdings in 2019 Q4: LITHIA MTRS INC COM(LAD) 10.17%, P G & E CORP(PCG) 8.44%, FRANKLIN RES INC 7.84%, ALLERGAN PFD CONV SER A 7.35%, Teva Pharmaceutical Industries Limited(TEVA) 7.32%.
- Portfolio Value
- $3.22B
- Current Holdings
- 21 stocks
- New / Increased
- 3 / 1
- Reduced / Exited
- 7 / 2
Current Holdings
| 1 | LITHIA MTRS INC COMLAD | 0.33 | 10.17% | 2.23 -3.21% | $147.00 | - | $51.07 | -0.07 | 1.75 | +$0.21B+187.82% | Reduced |
| 2 | P G & E CORPPCG | 0.27 | 8.44% | 25.00 - | $10.87 | - | $17.80 | 0.00 | 1.00 | -$0.17B-38.93% | Held |
| 3 | FRANKLIN RES INCCUSIP 354613101 | 0.25 | 7.84% | 9.72 -0.56% | $25.98 | - | $36.07 | -0.05 | 4.25 | -$0.10B-27.97% | Reduced |
| 4 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.24 | 7.35% | 1.24 | $191.17 | - | $191.17 | +1.24 | 0.25 | $0.00B0.00% | New |
| 5 | Teva Pharmaceutical Industries LimitedTEVA | 0.24 | 7.32% | 24.05 - | $9.80 | $20.11 +105.20% | $14.93 | 0.00 | 2.50 | +$0.12B+34.74% | Held |
| 6 | OREILLY AUTOMOTIVE INC COMORLY | 0.23 | 7.07% | 0.52 -2.70% | $438.26 | - | $216.20 | -0.01 | 2.50 | +$0.12B+102.71% | Reduced |
| 7 | WILLIS TOWERS WATSON PLC LTD SHSWLTW | 0.22 | 6.86% | 1.09 -1.42% | $201.94 | - | $122.28 | -0.02 | 3.25 | +$0.09B+65.15% | Reduced |
| 8 | ASBURY AUTOMOTIVE GROUP INC COMABG | 0.21 | 6.61% | 1.90 - | $111.79 | - | $64.17 | 0.00 | 2.50 | +$0.09B+74.22% | Held |
| 9 | U HAUL HOLDING COMPANY COMUHAL | 0.21 | 6.55% | 0.56 - | $375.82 | - | $366.08 | 0.00 | 3.25 | +$0.01B+2.66% | Held |
| 10 | Meta Platforms, Inc.META | 0.21 | 6.50% | 1.02 -0.49% | $205.25 | $612.96 +198.64% | $131.96 | -0.01 | 1.25 | +$0.49B+364.50% | Reduced |
| 11 | Kinder Morgan, Inc.KMI | 0.18 | 5.61% | 8.53 - | $21.17 | $27.26 +28.77% | $15.15 | 0.00 | 2.00 | +$0.10B+79.98% | Held |
| 12 | ALPHABET INC CAP STK CL AGOOGL | 0.16 | 5.04% | 0.12 -2.50% | $1339.39 | $375.95 -71.93% | $1129.19 | -0.00 | 1.75 | -$0.09B-66.71% | Reduced |
| 13 | CAMPING WORLD HLDGS INCCUSIP 13462K109 | 0.09 | 2.80% | 6.11 +11.91% | $14.74 | - | $15.64 | +0.65 | 1.50 | -$0.01B-5.76% | Increased |
| 14 | BRISTOL MYERS SQUIBB COCUSIP 110122157 | 0.07 | 2.17% | 23.20 | $3.01 | - | $3.01 | +23.20 | 0.25 | $0.00B0.00% | New |
| 15 | TRANSMEDICS GROUP INCCUSIP 89377M109 | 0.07 | 2.07% | 3.50 - | $19.01 | - | $25.09 | 0.00 | 0.75 | -$0.02B-24.24% | Held |
| 16 | SUBURBAN PROPANE PARTNERS LCUSIP 864482104 | 0.07 | 2.03% | 2.99 - | $21.85 | - | $23.75 | 0.00 | 2.75 | -$0.01B-8.00% | Held |
| 17 | O-I GLASS INCCUSIP 67098H104 | 0.06 | 1.81% | 4.87 | $11.93 | - | $11.93 | +4.87 | 0.25 | $0.00B0.00% | New |
| 18 | SCULPTOR CAP MGMTCUSIP 811246107 | 0.05 | 1.41% | 2.06 -7.42% | $22.10 | - | $19.48 | -0.17 | 0.50 | +$0.01B+13.45% | Reduced |
| 19 | AKEBIA THERAPEUTICS INCCUSIP 00972D105 | 0.04 | 1.11% | 5.66 - | $6.32 | - | $1.81 | 0.00 | 1.50 | +$0.03B+249.96% | Held |
| 20 | PACIFIC DRILLING SA LUXEMBOUCUSIP L7257P205 | 0.03 | 0.94% | 7.41 - | $4.08 | - | $13.35 | 0.00 | 1.25 | -$0.07B-69.44% | Held |
| 21 | CLEAR CHANNEL OUTDOOR HOLDINCCO | 0.01 | 0.30% | 3.35 - | $2.86 | - | $4.72 | 0.00 | 0.75 | -$0.01B-39.41% | Held |
Showing 1-21 of 21
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2019 Q4.
| 1 | CELGENE CORPCUSIP 151020104 | 6.75 | 0.75 | $94.34 | $99.30 | +$0.03B+5.26% |
| 2 | ALTABA INC COMCUSIP 021346101 | 12.65 | 0.25 | $19.48 | $19.48 | $0.00B0.00% |
Showing 1-2 of 2
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.